Literature DB >> 17875821

Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.

Miki Nagase1, Hiromitsu Matsui, Shigeru Shibata, Takanari Gotoda, Toshiro Fujita.   

Abstract

Aldosterone is implicated in the pathogenesis of proteinuria and chronic kidney disease. We previously demonstrated the contribution of elevated serum aldosterone in the early nephropathy of SHR/NDmcr-cp (SHR/cp), a rat model of metabolic syndrome. In the present study, we investigated the effect of salt loading on renal damage in SHR/cps and explored the underlying mechanisms. SHR/cps fed a high-sodium diet for 4 weeks developed severe hypertension, massive proteinuria, and advanced renal lesions. High salt also worsened glomerular podocyte impairment. Surprisingly, selective mineralocorticoid receptor (MR) antagonist eplerenone dramatically ameliorated the salt-induced proteinuria and renal injury in SHR/cps. Although salt loading reduced circulating aldosterone, it increased nuclear MR and expression of aldosterone effector kinase Sgk1 in the kidney. Gene expressions of transforming growth factor-beta1 and plasminogen activator inhibitor-1 were also enhanced in the kidneys of salt-loaded SHR/cps, and eplerenone completely inhibited these injury markers. To clarify the discrepancy between decreased aldosterone and enhanced MR signaling by salt, we further investigated the role of oxidative stress, a putative key factor mediating salt-induced tissue damage. Interestingly, antioxidant Tempol attenuated the salt-evoked MR upregulation and Sgk1 induction and alleviated proteinuria and renal histological abnormalities, suggesting the involvement of oxidative stress in salt-induced MR activation. MR activation by salt was not attributed to increased serum corticosterone or reduced 11beta-hydroxysteroid dehydrogenase type 2 activity. In conclusion, sodium loading exacerbated proteinuria and renal injury in metabolic syndrome rats. Salt reduced circulating aldosterone but caused renal MR activation at least partially via induction of oxidative stress, and eplerenone effectively improved the nephropathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875821     DOI: 10.1161/HYPERTENSIONAHA.107.091058

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  62 in total

Review 1.  The role of aldosterone in the metabolic syndrome.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

2.  Reactive oxygen species, NADPH oxidases, and hypertension.

Authors:  Srinivasa Raju Datla; Kathy K Griendling
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

3.  Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.

Authors:  Makiko Oboshi; Yoshiro Naito; Hisashi Sawada; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Shinichi Hirotani; Toshiaki Mano; Takeshi Tsujino; Tohru Masuyama
Journal:  Hypertens Res       Date:  2016-07-21       Impact factor: 3.872

Review 4.  Aldosterone and CKD in metabolic syndrome.

Authors:  Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 5.  The role of ENaC in vascular endothelium.

Authors:  Kristina Kusche-Vihrog; Pia Jeggle; Hans Oberleithner
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

6.  Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; K Bridget Brosnihan; Javad Habibi; Roger D Tilmon; James R Sowers; Carlos M Ferrario
Journal:  Am J Nephrol       Date:  2010-11-02       Impact factor: 3.754

Review 7.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 8.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

9.  Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels.

Authors:  F L Fernandes-Rosa; A C Bueno; R Molina de Souza; M de Castro; J Ernesto dos Santos; M C Foss; M-C Zennaro; H Bettiol; M A Barbieri; S R Antonini
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

Review 10.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.